Literature DB >> 915603

Irreversible glomerular damage following heterologous serum albumin overload.

D J Davies, D B Brewer.   

Abstract

Rats injected intraperitoneally with 1 g of bovine serum albumin (BSA) daily for 5 days develop heavy proteinuria and there is swelling and loss of the foot processes of the glomerular epithelial cells. Initially the urinary protein consists of about 55 per cent. BSA and about 40 per cent. rat serum albumin. Proteinuria persists when the injections of BSA are stopped. BSA disappears from the urine and 80-90 per cent. of the urinary protein is rat serum albumin. The persisting proteinuria is caused by glomerular damage resulting from disruption and necrosis of the glomerular epithelial cells leading to complete sclerosis of glomeruli. This damage does not appear to be immunologically determined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915603     DOI: 10.1002/path.1711230106

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Interstitial nephritis induced by protein-overload proteinuria.

Authors:  A A Eddy
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Antibody induced injury to podocytes with proteinuria and foot process swelling in a transgenic (T16) mouse.

Authors:  H Ebrahim; D J Evans
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

4.  Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.

Authors:  Maire Beeken; Maja T Lindenmeyer; Simone M Blattner; Victoria Radón; Jun Oh; Tobias N Meyer; Diana Hildebrand; Hartmut Schlüter; Anna T Reinicke; Jan-Hendrik Knop; Anuradha Vivekanandan-Giri; Silvia Münster; Marlies Sachs; Thorsten Wiech; Subramaniam Pennathur; Clemens D Cohen; Matthias Kretzler; Rolf A K Stahl; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 5.  Nephroprotective effect of ACE inhibitors.

Authors:  S Orth; M Nowicki; A Wiecek; E Ritz
Journal:  Drugs       Date:  1993       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.